DIAN Target Validation Symposium Agenda
Welcome/Open Remarks: May 25
Dr. Randall Bateman, MD- Washington University School of Medicine, St. Louis, Mo
Presentations
Primers on Target Validation: How we validate and factors that influence robustness- 8:45am
Moderator: Dr. Todd Golde, MD, PhD
Presenters:
Dr. Eric Karran, PhD– Vice President, Distinguished Research Fellow, Neuroscience and Ophthalmology Discovery Research at AbbVie
Dr. Geoffrey A. Kerchner, MD, PhD– Vice President and Global Head of Early Development in Neuroscience and Rare Disease at F. Hoffman- La Roche, Ltd
Panelist: Dr. Jaren Landen, PhD; Dr. Eric Karran, PhD, Dr. Geoffrey Kerchner, MD, PhD
Known Amyloid Target Validation- 10:30am
Moderator: Dr. Tammie Benzinger, MD, PhD
Presenters:
Dr. Lucia Chavez-Gutierrez, PhD– VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium
Dr. Jasmeer Chhawtal, MD, PhD– Harvard Medical School, Boston, MA
Panelist: Randall J. Bateman, MD; Dr. Colin Masters, MD; Dr. Lucia Chavez-Gutierrez, PhD; Dr. Jasmeer Chhawtal, MD, PhD
Known Tau Target Validation- 1:00pm
Moderator: Dr. Eric McDade, DO
Presenters:
Dr. Nicolas Barthelemy, PhD– Washington University School of Medicine, St. Louis, MO
Dr. Oskar Hansson, PhD– Lund University, Lund, Sweden
Panelist: Dr. Judith Steen, PhD; Dr. Jeff Dage, PhD; Dr. Nicolas Barthelemy, PhD; Dr. Oskar Hansson, PhD
Potential Omics Target Validation-2:45pm
Moderator: Dr. Allan Levey, MD, PhD
Presenters:
Dr. Erik Johnson, MD, PhD– Emory University, Atlanta, Georgia
Dr. Celeste Karch, PhD– Washington University School of Medicine, St. Louis, Mo
Panelists: Dr. Li-Huei Tsai, PhD; Dr. Laura Ibanez, PhD; Dr. Erik Johnson, MD, PhD; Dr. Celeste Karch, PhD
Opening Remarks: May 26
Dr. Randall Bateman, MD- Washington University of Medicine, St. Louis, Mo
Presentations
Biomarkers for non-Amyloid/non Tau Target Validation- 8:45am
Moderator: Dr. Johannes Levin, MD
Presenters:
Dr. Charlotte Teunissen, PhD – Amsterdam University Medical Centers, Amsterdam, Netherlands
Dr. Marc Suárez-Calvet, MD, PhD– BarcelonaBeta Brain Research Center (BBRC), Barcelona, Spain
Panelists: Dr. Naresha Saligrama, PhD; Dr. Pedro Rosa-Neto, MD, PhD; Dr. Charlotte Teunissen, PhD; Dr. Marc Suarez- Calvet, MD, PhD
Clinical/Cognitive Validation of Targets- 10:30am
Moderator: Dr. Jorge Llibre-Guerra, MD, MS
Presenters:
Dr. Lynn Kramer, MD, FAAN– Chief Clinical Officer, Alzheimer’s Disease & Brain Health at Eisai
Dr. Paul Maruff, PhD– Chief Innovation Officer at Cogstate, Ltd and Professor at the Alzheimer’s Disease Research Group, Florey Institute for Neuroscience at the University of Melbourne, Australia
Panelists: Dr. Jason Hassenstab, PhD; Dr. Eric McDade, DO; Dr. Kathy Welsh-Bohmer, PhD; Dr. Lynn Kramer, MD; Dr. Paul Maruff, PhD
Protective/Escapee-1:00pm
Moderator: Dr. Alison Goate, DPhil
Presenter:
Dr. Yakeel T. Quiroz, PhD– Harvard Medical School, Boston, MA
Panelists: Dr. Jorge Llibre-Guerra, MD, MS; Dr. Alison Goate, DPhil; Dr. Yakeel Quiroz, PhD
Disease Modification- 1:45pm
Moderator: Dr. Randall J. Bateman, MD
Presenters:
Dr. Randall Bateman, MD– Washington University School of Medicine, St, Louis Mo
Dr. Alireza Atri, MD, PhD– Director at Banner Sun Health Research Institute, Sun City , AZ
Panelist: Dr. Allan Levey, MD, PhD; Dr. Michael Irizzary, MD, MPH; Dr. Randall Bateman, MD; Dr. Alireza Atri, MD, PhD